v3.26.1
Share Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Activity with Respect Status of, RSUs
A summary of the activity with respect to, and status of, RSUs during the years ended December 31, 2025 and 2024 is presented below:
Number of
 RSUs 		Weighted
 Average Grant
 Date Value
Unvested as of January 1, 20241,655,542$9.61 
Granted3,944,057$4.83 
Forfeited(557,975)$7.53 
Vested(2,512,989)$6.60 
Unvested as of December 31, 20242,528,635$6.16 
Granted3,631,591$2.92 
Forfeited(890,135)$8.25 
Vested(2,328,691)$3.83 
Unvested as of December 31, 20252,941,400$3.45 
Vested and unsettled as of December 31, 20251,667$6.22 
Schedule of Common Stock and Current Interest Rates The fair value of the Earn-out Shares was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Class A Common Stock and current interest rates. Below are the key assumptions used in valuing the Earn-out Shares:
 As of
July 19, 2023
PSQH Stock Price$9.08 
Volatility40.0%
Risk free rate of return4.6%
Expected term (in years)4.8 years
Schedule of Share-Based Compensation Expense
During the years ended December 31, 2025 and 2024, the Company recorded the following share-based compensation expense, related to RSUs, Earn-out Shares, and the Credova Merger:
For the year ended December 31,
20252024
Cost of sales$118,369 $172,310 
General and administrative6,914,343 11,250,957 
Sales and marketing2,100,325 6,620,093 
Research and development1,641,420 1,792,384 
Transaction costs incurred in connection with Credova Merger— 887,409 
 Total share-based compensation expense$10,774,457 $20,723,153